

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.01124095 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.75175097 |
| 3 | exogenous drug catabolic process (GO:0042738) | 8.71409177 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 8.61126002 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.61126002 |
| 6 | drug catabolic process (GO:0042737) | 8.58395324 |
| 7 | complement activation, alternative pathway (GO:0006957) | 8.08233521 |
| 8 | glyoxylate metabolic process (GO:0046487) | 7.84659047 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.83775274 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 7.83775274 |
| 11 | regulation of fibrinolysis (GO:0051917) | 7.77620647 |
| 12 | regulation of protein activation cascade (GO:2000257) | 7.64214269 |
| 13 | regulation of complement activation (GO:0030449) | 7.26636300 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 7.10976107 |
| 15 | ethanol oxidation (GO:0006069) | 6.88567397 |
| 16 | protein carboxylation (GO:0018214) | 6.67097733 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.67097733 |
| 18 | urea metabolic process (GO:0019627) | 6.54542746 |
| 19 | fibrinolysis (GO:0042730) | 6.15045857 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 6.14582762 |
| 21 | drug metabolic process (GO:0017144) | 6.11394892 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 6.05089855 |
| 23 | blood coagulation, intrinsic pathway (GO:0007597) | 5.96586119 |
| 24 | bile acid biosynthetic process (GO:0006699) | 5.93549748 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.91586713 |
| 26 | oxidative demethylation (GO:0070989) | 5.80687957 |
| 27 | ethanol metabolic process (GO:0006067) | 5.80471304 |
| 28 | urea cycle (GO:0000050) | 5.77229948 |
| 29 | imidazole-containing compound metabolic process (GO:0052803) | 5.56250709 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 5.50485511 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 5.44319588 |
| 32 | negative regulation of sterol transport (GO:0032372) | 5.44319588 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.42420575 |
| 34 | tyrosine metabolic process (GO:0006570) | 5.32682217 |
| 35 | cellular glucuronidation (GO:0052695) | 5.32550224 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 5.30458621 |
| 37 | bile acid metabolic process (GO:0008206) | 5.20410916 |
| 38 | regulation of plasminogen activation (GO:0010755) | 5.19261005 |
| 39 | protein activation cascade (GO:0072376) | 5.09755054 |
| 40 | uronic acid metabolic process (GO:0006063) | 5.05982958 |
| 41 | glucuronate metabolic process (GO:0019585) | 5.05982958 |
| 42 | complement activation, classical pathway (GO:0006958) | 4.82255129 |
| 43 | complement activation (GO:0006956) | 4.82011328 |
| 44 | S-adenosylmethionine metabolic process (GO:0046500) | 4.77803571 |
| 45 | negative regulation of protein activation cascade (GO:2000258) | 4.73602485 |
| 46 | glycine metabolic process (GO:0006544) | 4.73365894 |
| 47 | bile acid and bile salt transport (GO:0015721) | 4.55208286 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.54530464 |
| 49 | negative regulation of hemostasis (GO:1900047) | 4.54530464 |
| 50 | regulation of humoral immune response (GO:0002920) | 4.49895719 |
| 51 | glutamate metabolic process (GO:0006536) | 4.49102086 |
| 52 | acute-phase response (GO:0006953) | 4.45543691 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.35959771 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.35959771 |
| 55 | opsonization (GO:0008228) | 4.35254566 |
| 56 | alkaloid metabolic process (GO:0009820) | 4.33858827 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.28896269 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.26310788 |
| 59 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.26310788 |
| 60 | macromolecular complex remodeling (GO:0034367) | 4.21902076 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 4.21902076 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 4.21902076 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 4.16486887 |
| 64 | negative regulation of complement activation (GO:0045916) | 4.15577424 |
| 65 | arginine metabolic process (GO:0006525) | 4.15424664 |
| 66 | negative regulation of coagulation (GO:0050819) | 4.09616513 |
| 67 | phospholipid efflux (GO:0033700) | 4.09555352 |
| 68 | negative regulation of wound healing (GO:0061045) | 4.07781700 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 4.05931992 |
| 70 | aromatic amino acid family metabolic process (GO:0009072) | 3.99315339 |
| 71 | indole-containing compound catabolic process (GO:0042436) | 3.95433216 |
| 72 | indolalkylamine catabolic process (GO:0046218) | 3.95433216 |
| 73 | tryptophan catabolic process (GO:0006569) | 3.95433216 |
| 74 | cytolysis (GO:0019835) | 3.92987499 |
| 75 | cholesterol efflux (GO:0033344) | 3.92307963 |
| 76 | high-density lipoprotein particle remodeling (GO:0034375) | 3.85453504 |
| 77 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.80778195 |
| 78 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.80778195 |
| 79 | positive regulation of hemostasis (GO:1900048) | 3.80728331 |
| 80 | positive regulation of blood coagulation (GO:0030194) | 3.80728331 |
| 81 | intestinal cholesterol absorption (GO:0030299) | 3.78891897 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 3.78495557 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.75538074 |
| 84 | negative regulation of lipase activity (GO:0060192) | 3.70898477 |
| 85 | cellular amino acid catabolic process (GO:0009063) | 3.70609445 |
| 86 | cysteine metabolic process (GO:0006534) | 3.67512083 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 3.59470290 |
| 88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.58236934 |
| 89 | hormone catabolic process (GO:0042447) | 3.55774442 |
| 90 | xenobiotic metabolic process (GO:0006805) | 3.53681497 |
| 91 | reverse cholesterol transport (GO:0043691) | 3.52780518 |
| 92 | arginine catabolic process (GO:0006527) | 3.50928048 |
| 93 | positive regulation of coagulation (GO:0050820) | 3.47402835 |
| 94 | regulation of apoptotic cell clearance (GO:2000425) | 3.46854548 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.46182692 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 3.45899592 |
| 97 | acute inflammatory response (GO:0002526) | 3.43531206 |
| 98 | sulfur amino acid catabolic process (GO:0000098) | 3.38360788 |
| 99 | tryptophan metabolic process (GO:0006568) | 3.34950720 |
| 100 | ketone body metabolic process (GO:1902224) | 3.30747138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.64854762 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.35640382 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.62084127 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.42781201 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.41135899 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08359702 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93635849 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.79494594 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.78570755 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.60296140 |
| 11 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.21065503 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.06949865 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3852574 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96613110 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93954217 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84531062 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.77043873 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72771798 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.72769650 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65465860 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.65237304 |
| 22 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.59809003 |
| 23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38842490 |
| 24 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37821234 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31636927 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29829723 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29137339 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28471240 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26735575 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26261484 |
| 31 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21253894 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18967487 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13600695 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12952772 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11626712 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10599346 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03190978 |
| 38 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99734975 |
| 39 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.98552126 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94183637 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93602916 |
| 42 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93329849 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89386353 |
| 44 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86053473 |
| 45 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85256584 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82562787 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81462204 |
| 48 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80868559 |
| 49 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79127568 |
| 50 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79038517 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78787502 |
| 52 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.78206123 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77065772 |
| 54 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76568026 |
| 55 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76102511 |
| 56 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.75867750 |
| 57 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75028643 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74453954 |
| 59 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70711729 |
| 60 | CBP_21632823_ChIP-Seq_H3396_Human | 0.70665893 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69323687 |
| 62 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.68077121 |
| 63 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.66993527 |
| 64 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.66656422 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.65959764 |
| 66 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.65669599 |
| 67 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.65372756 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64770544 |
| 69 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64237451 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.63391466 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.62695960 |
| 72 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.62544752 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.62106174 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.61842247 |
| 75 | NFYA_21822215_ChIP-Seq_K562_Human | 0.61466476 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.60225572 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.59385555 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.57137383 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.55715452 |
| 80 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.55537900 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.55174266 |
| 82 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.54574003 |
| 83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.54559509 |
| 84 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.54066324 |
| 85 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.53974345 |
| 86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.53228786 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.53083245 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52782760 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52714228 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 0.52312011 |
| 91 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.51682386 |
| 92 | NCOR_22424771_ChIP-Seq_293T_Human | 0.51354980 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.50991914 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50807161 |
| 95 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.50426891 |
| 96 | ERA_21632823_ChIP-Seq_H3396_Human | 0.50309091 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.50233252 |
| 98 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.49726279 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.49201607 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.49075127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.03284228 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.41595652 |
| 3 | MP0005360_urolithiasis | 6.33697549 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 6.15282867 |
| 5 | MP0005365_abnormal_bile_salt | 5.73871812 |
| 6 | MP0003195_calcinosis | 5.24547132 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.88247441 |
| 8 | MP0003252_abnormal_bile_duct | 3.76668564 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.59267670 |
| 10 | MP0003868_abnormal_feces_composition | 3.50448470 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.93664669 |
| 12 | MP0009697_abnormal_copulation | 2.63773717 |
| 13 | MP0005332_abnormal_amino_acid | 2.48114801 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.20676846 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.04959643 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.96048850 |
| 17 | MP0000609_abnormal_liver_physiology | 1.85213668 |
| 18 | MP0009840_abnormal_foam_cell | 1.77235895 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.72703040 |
| 20 | MP0010368_abnormal_lymphatic_system | 1.71075318 |
| 21 | MP0001764_abnormal_homeostasis | 1.60812403 |
| 22 | MP0005670_abnormal_white_adipose | 1.60339637 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.48041558 |
| 24 | MP0005408_hypopigmentation | 1.41963388 |
| 25 | MP0009053_abnormal_anal_canal | 1.32054843 |
| 26 | MP0002132_abnormal_respiratory_system | 1.24763347 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.16534622 |
| 28 | MP0002282_abnormal_trachea_morphology | 1.12923969 |
| 29 | MP0000598_abnormal_liver_morphology | 1.08183510 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.00526299 |
| 31 | MP0002249_abnormal_larynx_morphology | 0.96062338 |
| 32 | MP0005187_abnormal_penis_morphology | 0.92162962 |
| 33 | MP0001661_extended_life_span | 0.91743702 |
| 34 | MP0000566_synostosis | 0.90904975 |
| 35 | MP0008872_abnormal_physiological_respon | 0.89163256 |
| 36 | MP0003011_delayed_dark_adaptation | 0.88815975 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86375878 |
| 38 | MP0009642_abnormal_blood_homeostasis | 0.81290061 |
| 39 | MP0005451_abnormal_body_composition | 0.80726068 |
| 40 | MP0009763_increased_sensitivity_to | 0.79740083 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 0.79439117 |
| 42 | MP0009764_decreased_sensitivity_to | 0.79407352 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 0.79198159 |
| 44 | MP0005395_other_phenotype | 0.79055603 |
| 45 | MP0002168_other_aberrant_phenotype | 0.77709648 |
| 46 | MP0002971_abnormal_brown_adipose | 0.76132389 |
| 47 | MP0005376_homeostasis/metabolism_phenot | 0.75855015 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 0.73904845 |
| 49 | MP0003879_abnormal_hair_cell | 0.72723270 |
| 50 | MP0000604_amyloidosis | 0.68227391 |
| 51 | MP0008469_abnormal_protein_level | 0.68171044 |
| 52 | MP0003186_abnormal_redox_activity | 0.67566901 |
| 53 | MP0000467_abnormal_esophagus_morphology | 0.64138865 |
| 54 | MP0005535_abnormal_body_temperature | 0.64126095 |
| 55 | MP0003638_abnormal_response/metabolism_ | 0.59476160 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 0.58485018 |
| 57 | MP0001915_intracranial_hemorrhage | 0.55880781 |
| 58 | MP0003690_abnormal_glial_cell | 0.54484510 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 0.52971777 |
| 60 | MP0005266_abnormal_metabolism | 0.51867073 |
| 61 | MP0005647_abnormal_sex_gland | 0.47191964 |
| 62 | MP0008874_decreased_physiological_sensi | 0.45453093 |
| 63 | MP0005334_abnormal_fat_pad | 0.45097600 |
| 64 | MP0005083_abnormal_biliary_tract | 0.44873977 |
| 65 | MP0009785_altered_susceptibility_to | 0.44365861 |
| 66 | MP0005058_abnormal_lysosome_morphology | 0.42666150 |
| 67 | MP0000249_abnormal_blood_vessel | 0.42439622 |
| 68 | MP0005023_abnormal_wound_healing | 0.41506797 |
| 69 | MP0001881_abnormal_mammary_gland | 0.40146876 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.39871322 |
| 71 | MP0001756_abnormal_urination | 0.38699028 |
| 72 | MP0002796_impaired_skin_barrier | 0.36670289 |
| 73 | MP0004883_abnormal_blood_vessel | 0.36229008 |
| 74 | MP0002098_abnormal_vibrissa_morphology | 0.35559945 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.35425365 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.35402459 |
| 77 | MP0004043_abnormal_pH_regulation | 0.34997243 |
| 78 | MP0005448_abnormal_energy_balance | 0.33541814 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.33112486 |
| 80 | MP0002090_abnormal_vision | 0.32684305 |
| 81 | MP0002254_reproductive_system_inflammat | 0.32498648 |
| 82 | MP0003953_abnormal_hormone_level | 0.32234064 |
| 83 | MP0004130_abnormal_muscle_cell | 0.31196991 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.30010039 |
| 85 | MP0001851_eye_inflammation | 0.29717673 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.29413505 |
| 87 | MP0000639_abnormal_adrenal_gland | 0.28813796 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.28551965 |
| 89 | MP0005248_abnormal_Harderian_gland | 0.28546432 |
| 90 | MP0005166_decreased_susceptibility_to | 0.26029759 |
| 91 | MP0005164_abnormal_response_to | 0.26003905 |
| 92 | MP0003075_altered_response_to | 0.25806031 |
| 93 | MP0009115_abnormal_fat_cell | 0.25151879 |
| 94 | MP0000371_diluted_coat_color | 0.24314734 |
| 95 | MP0003718_maternal_effect | 0.24058297 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.23513993 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 0.23174718 |
| 98 | MP0003878_abnormal_ear_physiology | 0.23174718 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.22537166 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.22226138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.58437380 |
| 2 | Complement deficiency (HP:0004431) | 9.32797480 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.78333109 |
| 4 | Abnormality of complement system (HP:0005339) | 7.41483071 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.24517652 |
| 6 | Joint hemorrhage (HP:0005261) | 6.68502611 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 6.50100817 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.16874618 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.77456463 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.44246918 |
| 11 | Glomerulonephritis (HP:0000099) | 5.29475874 |
| 12 | Xanthomatosis (HP:0000991) | 5.09174432 |
| 13 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.88311010 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.16149084 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 4.14978914 |
| 16 | Spontaneous abortion (HP:0005268) | 4.11516478 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.00814805 |
| 18 | Nephritis (HP:0000123) | 3.99819073 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99295428 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.69226662 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.60798143 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.59584163 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.38514000 |
| 24 | Hyperammonemia (HP:0001987) | 3.20695086 |
| 25 | Delayed CNS myelination (HP:0002188) | 3.19781901 |
| 26 | Hyperglycinemia (HP:0002154) | 3.16506973 |
| 27 | Fair hair (HP:0002286) | 3.15699980 |
| 28 | Fat malabsorption (HP:0002630) | 3.11142258 |
| 29 | Epidermoid cyst (HP:0200040) | 3.10249836 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07170413 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.07170413 |
| 32 | Neonatal hypoglycemia (HP:0001998) | 2.89145185 |
| 33 | Hypercholesterolemia (HP:0003124) | 2.85385862 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.77062359 |
| 35 | Mitral stenosis (HP:0001718) | 2.76671661 |
| 36 | Menorrhagia (HP:0000132) | 2.71700366 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.71241807 |
| 38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.69783638 |
| 39 | Hyperglycinuria (HP:0003108) | 2.67314593 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 2.67279313 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67263724 |
| 42 | Osteomalacia (HP:0002749) | 2.60749613 |
| 43 | Vascular calcification (HP:0004934) | 2.57553679 |
| 44 | Rickets (HP:0002748) | 2.56107810 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.49851390 |
| 46 | Reduced antithrombin III activity (HP:0001976) | 2.46796608 |
| 47 | Gingival bleeding (HP:0000225) | 2.46030843 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.44220300 |
| 49 | Generalized hypopigmentation of hair (HP:0011358) | 2.43909526 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.41642311 |
| 51 | Thrombophlebitis (HP:0004418) | 2.32049800 |
| 52 | Purpura (HP:0000979) | 2.29382544 |
| 53 | Arthropathy (HP:0003040) | 2.28088308 |
| 54 | Pulmonary embolism (HP:0002204) | 2.27287968 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.23707285 |
| 56 | Steatorrhea (HP:0002570) | 2.22003374 |
| 57 | Metabolic acidosis (HP:0001942) | 2.20388456 |
| 58 | Hypophosphatemic rickets (HP:0004912) | 2.12585247 |
| 59 | Ketosis (HP:0001946) | 2.11934387 |
| 60 | Cholelithiasis (HP:0001081) | 2.05330868 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.4904142 |
| 62 | Deep venous thrombosis (HP:0002625) | 10.2131658 |
| 63 | Gangrene (HP:0100758) | 1.98210417 |
| 64 | Skin nodule (HP:0200036) | 1.92928180 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 1.89119527 |
| 66 | Blue irides (HP:0000635) | 1.86636134 |
| 67 | Enlarged kidneys (HP:0000105) | 1.83121166 |
| 68 | Elevated alkaline phosphatase (HP:0003155) | 1.81759469 |
| 69 | Hydroxyprolinuria (HP:0003080) | 1.80689276 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 1.80689276 |
| 71 | Abnormality of the Achilles tendon (HP:0005109) | 1.80672374 |
| 72 | Myocardial infarction (HP:0001658) | 1.79060141 |
| 73 | Abnormal tarsal ossification (HP:0008369) | 1.78095543 |
| 74 | Bifid scrotum (HP:0000048) | 1.77686604 |
| 75 | Hyperphosphaturia (HP:0003109) | 1.73930124 |
| 76 | Increased serum ferritin (HP:0003281) | 1.71909702 |
| 77 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.69341144 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 1.68482996 |
| 79 | Cholecystitis (HP:0001082) | 1.68482996 |
| 80 | Cerebral palsy (HP:0100021) | 1.66615788 |
| 81 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.66017935 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 1.65950385 |
| 83 | Irritability (HP:0000737) | 1.63666188 |
| 84 | Glycosuria (HP:0003076) | 1.59473688 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 1.59473688 |
| 86 | Neonatal onset (HP:0003623) | 1.58126868 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 1.57938428 |
| 88 | Abnormality of vitamin metabolism (HP:0100508) | 1.57197114 |
| 89 | Gout (HP:0001997) | 1.55297314 |
| 90 | Alkalosis (HP:0001948) | 1.53805871 |
| 91 | Atrioventricular block (HP:0001678) | 1.52470378 |
| 92 | Pancreatitis (HP:0001733) | 1.51741013 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.51143111 |
| 94 | Increased serum pyruvate (HP:0003542) | 1.49789762 |
| 95 | Epistaxis (HP:0000421) | 1.45860324 |
| 96 | Impaired platelet aggregation (HP:0003540) | 1.45494362 |
| 97 | Abnormal platelet function (HP:0011869) | 1.45494362 |
| 98 | Increased mean platelet volume (HP:0011877) | 1.44769836 |
| 99 | Poikilocytosis (HP:0004447) | 1.43550858 |
| 100 | Abnormal urine phosphate concentration (HP:0012599) | 1.43024393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.64572620 |
| 2 | MUSK | 4.15982062 |
| 3 | ERN1 | 3.96630513 |
| 4 | FGFR4 | 3.70585796 |
| 5 | AKT3 | 3.40296676 |
| 6 | SIK1 | 3.20483438 |
| 7 | EPHA3 | 3.11419264 |
| 8 | RIPK1 | 2.79882569 |
| 9 | PKN2 | 2.62219891 |
| 10 | PIK3CA | 2.51517150 |
| 11 | FER | 2.40298399 |
| 12 | TNK2 | 2.22820461 |
| 13 | FRK | 1.97506088 |
| 14 | BRSK2 | 1.97270010 |
| 15 | ICK | 1.85741911 |
| 16 | PRKAA2 | 1.74775970 |
| 17 | TAOK3 | 1.66045405 |
| 18 | EPHA2 | 1.61873032 |
| 19 | FGFR3 | 1.53388204 |
| 20 | MYLK | 1.50084652 |
| 21 | PRKACG | 1.39629676 |
| 22 | IRAK1 | 1.36150396 |
| 23 | ERBB2 | 1.29049717 |
| 24 | MAP3K3 | 1.25958247 |
| 25 | PRKAA1 | 1.14819050 |
| 26 | BCKDK | 1.10296112 |
| 27 | CAMK1D | 1.06079130 |
| 28 | MST1R | 1.05493422 |
| 29 | IGF1R | 1.05262649 |
| 30 | TYK2 | 0.97109089 |
| 31 | PAK3 | 0.95026123 |
| 32 | MAP2K6 | 0.93332866 |
| 33 | NLK | 0.89806177 |
| 34 | PRPF4B | 0.87324658 |
| 35 | EEF2K | 0.85053841 |
| 36 | PIK3CG | 0.84332612 |
| 37 | GSK3A | 0.83487736 |
| 38 | MAPKAPK3 | 0.82654175 |
| 39 | MAP2K4 | 0.82103277 |
| 40 | EPHB1 | 0.81749922 |
| 41 | PDPK1 | 0.81366329 |
| 42 | MARK2 | 0.81237492 |
| 43 | PTK6 | 0.79270737 |
| 44 | MAPK11 | 0.76609095 |
| 45 | PTK2 | 0.75334210 |
| 46 | MTOR | 0.71795829 |
| 47 | SGK494 | 0.70303766 |
| 48 | SGK223 | 0.70303766 |
| 49 | MAP3K2 | 0.69108063 |
| 50 | RET | 0.69004998 |
| 51 | CHUK | 0.68824691 |
| 52 | PRKCG | 0.68040797 |
| 53 | MAPK7 | 0.67551634 |
| 54 | GRK1 | 0.66874891 |
| 55 | FGFR1 | 0.66380296 |
| 56 | EIF2AK3 | 0.65932593 |
| 57 | JAK1 | 0.65780810 |
| 58 | INSRR | 0.64110183 |
| 59 | TBK1 | 0.63977815 |
| 60 | WNK4 | 0.63730241 |
| 61 | SGK2 | 0.63064729 |
| 62 | MAP3K6 | 0.62965096 |
| 63 | PRKCZ | 0.61005953 |
| 64 | PDK1 | 0.59655589 |
| 65 | MAP3K7 | 0.59638029 |
| 66 | MAP3K13 | 0.59554383 |
| 67 | PRKACA | 0.59499725 |
| 68 | MAPK15 | 0.58463206 |
| 69 | LATS1 | 0.57509650 |
| 70 | NTRK3 | 0.53271237 |
| 71 | STK38 | 0.53243779 |
| 72 | SGK1 | 0.50594503 |
| 73 | CSNK1E | 0.50230478 |
| 74 | CDK6 | 0.49424527 |
| 75 | NEK6 | 0.49059412 |
| 76 | PRKCI | 0.48480581 |
| 77 | HIPK2 | 0.47801960 |
| 78 | IKBKE | 0.46358353 |
| 79 | PRKG1 | 0.44535149 |
| 80 | ABL2 | 0.44035723 |
| 81 | MAPK3 | 0.43369632 |
| 82 | TRPM7 | 0.42203584 |
| 83 | RPS6KA3 | 0.41343603 |
| 84 | CDK7 | 0.41026931 |
| 85 | IRAK3 | 0.40830573 |
| 86 | MATK | 0.39507202 |
| 87 | CSNK1D | 0.38167595 |
| 88 | PRKD1 | 0.38106397 |
| 89 | MAP4K2 | 0.37485521 |
| 90 | MAPK4 | 0.36432977 |
| 91 | CAMK1G | 0.36194254 |
| 92 | DAPK2 | 0.35707756 |
| 93 | CDK12 | 0.33674632 |
| 94 | SGK3 | 0.33368989 |
| 95 | MET | 0.32721523 |
| 96 | PRKCE | 0.32516391 |
| 97 | MAPK1 | 0.31508662 |
| 98 | NEK9 | 0.31495453 |
| 99 | CSNK1A1 | 0.31195933 |
| 100 | SRC | 0.30424576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.44175495 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.15449211 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94976203 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.85317065 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.39327303 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.23201065 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04691889 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.80813968 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.78542371 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.77980561 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.76873539 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72423544 |
| 13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.59428883 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53912008 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42900276 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.41492812 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.28844552 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.17426812 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.12295063 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96911847 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.93592247 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75308355 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.74081725 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56696045 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.50761706 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50405600 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47189028 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.45034409 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43869118 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41733328 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37404988 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35211471 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.32245785 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.28628421 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20072614 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19948876 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19010914 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16193666 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15734319 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.10247766 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09851841 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99995588 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97640881 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95412352 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92634933 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.88873288 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83441653 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82473277 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79780745 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77266853 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76742446 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75568882 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74377986 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69346795 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66428745 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.65461654 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61287002 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47982005 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44067558 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36597803 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34340522 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.32293801 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.29965619 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29316021 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28991308 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25638023 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19937133 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13968735 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11016416 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10711827 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.10711696 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10536240 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.07443228 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05982285 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05210622 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.04387579 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.03837936 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.02923275 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01680324 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00964319 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2475955 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2325430 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2161559 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1860731 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1830836 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1780912 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1592655 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1525129 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1272508 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1046353 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1030319 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1003443 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0890243 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0796227 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0575610 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.0539328 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0443810 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0434250 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0382711 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0328182 |

